reglab/housing_qa huggingface dataset:
IN Code § 16-41-16-6 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-6. Secure Area

Sec. 6. As used in this chapter, "secure area" means an area that is designed and maintained to prevent the entry of unauthorized persons.[Pre-1993 Recodification Citation: 16-1-9.7-5.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-16-7 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-7. Treatment of Infectious Waste

Sec. 7. (a) Before infectious waste is placed in an area that is not a secure area and before the waste is sent for final disposal, all infectious waste must be:(1) effectively treated on site; or(2) transported off site for effective treatment;according to rules adopted under section 8 of this chapter.(b) A facility shall treat liquid infectious waste or excreta that are infectious waste as required by subsection (a) or flush the liquid infectious waste or excreta that are infectious waste in compliance with rules adopted under IC 4-22-2.[Pre-1993 Recodification Citation: 16-1-9.7-7.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-16-7.5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-7.5. Treatment of Noninfectious Waste

Sec. 7.5. Any waste that is not infectious waste (as defined in section 4(c) of this chapter) must be double bagged and tied to protect handlers.As added by P.L.146-1996, SEC.7.
IN Code § 16-41-16-7.6 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-7.6. Disposition of a Miscarried Fetus or an Aborted Fetus

Sec. 7.6. (a) This section applies to a person or facility possessing either an aborted fetus or a miscarried fetus.(b) Within ten (10) business days after a miscarriage occurs or an abortion is performed, a person or facility described in subsection (a) shall:(1) conduct the final disposition of a miscarried fetus or an aborted fetus in the manner required by IC 16-21-11-6 or IC 16-34-3-4; or(2) ensure that the miscarried fetus or aborted fetus is preserved until final disposition under IC 16-21-11-6 or IC 16-34-3-4 occurs.As added by P.L.213-2016, SEC.26.
IN Code § 16-41-16-8 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-8. Rules

Sec. 8. (a) After consulting with an advisory committee composed of representatives of persons or facilities that handle infectious wastes, the state department shall adopt rules under IC 4-22-2 necessary to carry out this chapter.(b) The state department shall adopt rules under this section after considering the guidelines of the following:(1) United States Environmental Protection Agency.(2) United States Centers for Disease Control.(3) United States Occupational Safety and Health Administration.(4) State department of labor.(5) State department of environmental management.(c) The state department shall adopt rules under this section that establish an alternative to 410 IAC 1-3-28 to allow a person or facility that transports infectious waste offsite to label each container of infectious waste in a manner that:(1) does not specifically identify the generating facility or treatment facility; and(2) ensures that the identity of the generating facility or treatment facility may be readily obtained based on the label information.[Pre-1993 Recodification Citation: 16-1-9.7-8.]As added by P.L.2-1993, SEC.24. Amended by P.L.128-1997, SEC.9.
IN Code § 16-41-16-9 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-9. Inspections on Private Property

Sec. 9. (a) The state department may designate an agent who may enter on private property to inspect for and investigate possible violations of this chapter or rules adopted under this chapter if the following conditions are met:(1) The agent has probable cause to believe that evidence of a health threat exists on private property.(2) The agent presents proper credentials.(3) Emergency circumstances exist or a warrant is issued.(b) This section does not impair the authority of the state department to enter public or private property as authorized by law.[Pre-1993 Recodification Citation: 16-1-9.5-10(a) part.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-16-10 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-10. Orders of Compliance; Civil Penalties

Sec. 10. (a) The state department may commence an action under IC 4-21.5-3-6 or IC 4-21.5-4 for issuance of an order of compliance and a civil penalty not to exceed one thousand dollars ($1,000) per violation per day against a person who:(1) fails to comply with this chapter or a rule adopted under this chapter; or(2) interferes with or obstructs the state department or the state department's designated agent in the performance of official duties under this chapter or a rule adopted under this chapter.(b) The state department may commence an action against a facility licensed by the state department under either subsection (a) or the licensure statute for that facility, but the state department may not bring an action arising out of one (1) incident under both statutes.[Pre-1993 Recodification Citation: 16-1-9.5-10(b) part, (c) part.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-16-11 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 16. Communicable Disease: Treatment of Infectious Waste|16-41-16-11. Violations

Sec. 11. (a) Except as otherwise provided, a person who recklessly violates or fails to comply with this chapter commits a Class B misdemeanor.(b) Each day a violation continues constitutes a separate offense.[Pre-1993 Recodification Citation: 16-1-35-1.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-1 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-1. Waste Blood Specimen

Sec. 1. As used in this chapter, "waste blood specimen" means a blood sample or a solid, liquid, or semiliquid blood product that:(1) has served the intended purpose under section 4 of this chapter; or(2) has served the natural, biological, medical, or intended purpose and has been discarded or accumulated for discard from a use other than as provided under section 10(a)(5) of this chapter.[Pre-1993 Recodification Citation: 16-8-6-1.6.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-2 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-2. Examinations; Religious Exemption

Sec. 2. (a) Subject to subsection (d), every infant shall be given examinations at the earliest feasible time for the detection of the following disorders:(1) Phenylketonuria.(2) Hypothyroidism.(3) Hemoglobinopathies, including sickle cell anemia.(4) Galactosemia.(5) Maple Syrup urine disease.(6) Homocystinuria.(7) Inborn errors of metabolism that result in an intellectual disability and that are designated by the state department.(8) Congenital adrenal hyperplasia.(9) Biotinidase deficiency.(10) Disorders detected by tandem mass spectrometry or other technologies with the same or greater detection capabilities as tandem mass spectrometry, if the state department determines that the technology is available for use by a designated laboratory under section 7 of this chapter.(11) Spinal muscular atrophy.(12) Severe combined immunodeficiency.(13) Beginning July 1, 2020, Krabbe disease.(14) Beginning July 1, 2020, Pompe disease.(15) Beginning July 1, 2020, Hurler syndrome (MPS1).(16) Adrenoleukodystrophy (ALD).(b) Subject to subsection (d), every infant shall be given a physiologic hearing screening examination at the earliest feasible time for the detection of hearing impairments.(c) Subject to subsection (d), every infant shall be given a pulse oximetry screening examination in accordance with rules adopted by the department for the detection of low oxygen levels. Section 10(a)(2) of this chapter does not apply to this subsection.(d) If a parent of an infant objects in writing, for reasons pertaining to religious beliefs only, the infant is exempt from the examinations required by this chapter.[Pre-1993 Recodification Citation: 16-8-6-1.]As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.2; P.L.149-2001, SEC.3; P.L.229-2011, SEC.165; P.L.117-2015, SEC.34; P.L.17-2018, SEC.1; P.L.1-2019, SEC.1; P.L.19-2020, SEC.1.
IN Code § 16-41-17-3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-3. Educational Program

Sec. 3. The state department shall conduct an intensive educational program among physicians, hospitals, public health nurses, and the public concerning the disorders listed in section 2 of this chapter. The educational program must include information about:(1) the nature of the disorders; and(2) examinations for the detection of the disorders in infancy;so that measures may be taken to prevent the intellectual disabilities, medical complications, or mortality resulting from the disorders.[Pre-1993 Recodification Citation: 16-8-6-2.]As added by P.L.2-1993, SEC.24. Amended by P.L.117-2015, SEC.35.
IN Code § 16-41-17-4 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-4. Tests

Sec. 4. After consultation with medical authorities, the state department shall require appropriate tests to be used in the detection of disorders listed in section 2 of this chapter.[Pre-1993 Recodification Citation: 16-8-6-3.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-5. Detection Plans and Procedures

Sec. 5. The state department and all local boards of health shall encourage and promote the development of plans and procedures for the detection of the disorders listed in section 2 of this chapter in all local health jurisdictions of Indiana.[Pre-1993 Recodification Citation: 16-8-6-4.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-6 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-6. Reports

Sec. 6. (a) The state department shall provide forms on which the results of tests performed on each child for the disorders listed in section 2 of this chapter shall be reported to the state department by physicians and hospitals.(b) The state department shall ascertain at least quarterly the extent of such testing and the findings shall be reported to all hospitals, physicians, and other groups interested in child welfare.[Pre-1993 Recodification Citation: 16-8-6-5.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-7 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-7. Testing Laboratories

Sec. 7. (a) The state department shall designate at least one (1) laboratory for testing for disorders listed in section 2(a) of this chapter.(b) The designated laboratories shall perform tests on all infants for the detection of disorders under section 2(a) of this chapter.(c) This section does not prevent other facilities from conducting tests for disorders under this chapter.[Pre-1993 Recodification Citation: 16-8-6-6(a).]As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.3.
IN Code § 16-41-17-8 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-8. Blood Sample; Collection; Exceptions

Sec. 8. (a) Each hospital and physician shall:(1) subject to subsection (b), take or cause to be taken a blood sample from every infant born under the hospital's and physician's care; and(2) transport or cause to be transported each blood sample described in subdivision (1) to a laboratory designated under section 7 of this chapter;for testing for the disorders listed in section 2(a) of this chapter.(b) This subsection does not apply to preterm infants or newborn infants who receive a total exchange blood transfusion. Except as provided in subsection (c), a newborn infant's blood sample taken under subsection (a)(1) must be collected not earlier than twenty-four (24) hours after birth.(c) If a newborn infant is discharged before the time set forth in subsection (b), the blood sample must be collected not earlier than immediately before the infant's discharge, and a second blood sample must be collected after forty-eight (48) hours but not later than one hundred twenty (120) hours after birth.[Pre-1993 Recodification Citation: 16-8-6-6(b).]As added by P.L.2-1993, SEC.24. Amended by P.L.91-1999, SEC.4; P.L.38-2018, SEC.1.
IN Code § 16-41-17-9 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-9. Rules

Sec. 9. The state department shall adopt rules under IC 4-22-2 to carry out this chapter, including rules to ensure the following:(1) Proper and timely sample collection and transportation under section 8 of this chapter.(2) Quality testing procedures at the laboratories designated under section 7 of this chapter.(3) Uniform reporting procedures.(4) Centralized coordination, tracking, and follow-up.(5) Appropriate diagnosis and management of affected newborns and counseling and support programs for newborns' families.[Pre-1993 Recodification Citation: 16-8-6-7.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-10 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-10. Follow-Up Programs; Newborn Screening Fees; Waste Blood Specimen Confidentiality

Sec. 10. (a) The state department shall develop the following:(1) A registry for tracking and follow-up of all newborns and individuals for screening.(2) A centralized program that provides follow-up, diagnosis, management, and family counseling and support, including equipment, supplies, formula, and other materials, for all infants and individuals identified as having one (1) of the disorders listed in section 2 of this chapter.(3) A laboratory quality assurance program, including proficiency testing.(4) A statewide network of genetic evaluation and counseling services.(5) A system for using, for epidemiological survey and research purposes, any waste blood specimen generated under this chapter.(b) The program described in subsection (a) shall be funded by collection of a newborn screening fee for each newborn screened by a designated laboratory.(c) The state department shall set the fee and procedures for disbursement under rules adopted under IC 4-22-2. The fee must be based upon the projected cost of the program. The proposed fee must be approved by the budget agency before the rule is adopted.(d) The designated laboratory shall assess, collect, and deposit the fees established under subsection (c) in the newborn screening fund established under section 11 of this chapter.(e) The state department shall annually review the newborn screening fee.(f) Waste blood specimens used for the purpose of implementing the system described under subsection (a)(5) may not include the name or other identifying characteristics that would identify the individual submitting the specimen.[Pre-1993 Recodification Citation: 16-8-6-8 part.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-17-11 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 17. Prevention and Treatment Programs: Examination of Infants for Phenylketonuria, Hypothyroidism, and Other Disorders|16-41-17-11. Newborn Screening Fund

Sec. 11. (a) The newborn screening fund is established for the purpose of carrying out this chapter. The state department shall administer the fund.(b) The expenses of the newborn screening program shall be paid from money in the fund.(c) Money in the fund at the end of a state fiscal year does not revert to the state general fund.[Pre-1993 Recodification Citation: 16-8-6-9.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-18-2 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18. Prevention and Treatment Programs: Hemophilia Care and Treatment Program|16-41-18-2. Hemophilia

Sec. 2. As used in this chapter, "hemophilia" means a bleeding tendency resulting from a genetically determined deficiency factor in the blood.[Pre-1993 Recodification Citation: 16-1-14.5-1 part.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-18-3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18. Prevention and Treatment Programs: Hemophilia Care and Treatment Program|16-41-18-3. Care and Treatment Programs

Sec. 3. (a) The state department shall establish a program for the care and treatment of persons suffering from hemophilia.(b) The program established under subsection (a) shall assist persons who:(1) require continuing treatment with blood and blood derivatives to avoid crippling, extensive hospitalization, and other effects associated with the critical, chronic bleeding condition; and(2) are unable to pay for the entire cost of such services on a continuing basis despite the existence of various types of hospital medical insurance coverage, Medicare, Medicaid, other government assistance programs, and private charitable assistance programs.[Pre-1993 Recodification Citation: 16-1-14.5-2.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-18-5 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18. Prevention and Treatment Programs: Hemophilia Care and Treatment Program|16-41-18-5. Development of Care and Treatment Programs

Sec. 5. The state department may do the following:(1) Develop standards for determining eligibility for care and treatment under the hemophilia program established under this chapter.(2) Assist in the development and expansion of programs for the care and treatment of persons suffering from hemophilia, including the following:(A) Self-administration.(B) Prevention.(C) Home care.(D) Other medical and dental procedures and techniques designed to provide maximum control over bleeding episodes typical of the condition.(3) Extend financial assistance to persons suffering from hemophilia in obtaining blood, blood derivatives and concentrates, and other efficacious agents for use in hospital, medical, and dental facilities and at home or participate in the cost of blood processing to the extent that such support will facilitate the supplying of blood, blood derivatives and concentrates, and other efficacious agents to hemophiliac patients at an economical cost, thus increasing the effectiveness of the money appropriated to carry out this chapter.(4) Adopt rules necessary to carry out this chapter.[Pre-1993 Recodification Citation: 16-1-14.5-4.]As added by P.L.2-1993, SEC.24. Amended by P.L.87-1994, SEC.10.
IN Code § 16-41-18-6 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18. Prevention and Treatment Programs: Hemophilia Care and Treatment Program|16-41-18-6. Violations

Sec. 6. (a) Except as otherwise provided, a person who recklessly violates or fails to comply with this chapter commits a Class B misdemeanor.(b) Each day a violation continues constitutes a separate offense.[Pre-1993 Recodification Citation: 16-1-35-1.]As added by P.L.2-1993, SEC.24.
IN Code § 16-41-18.5-1 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18.5. Lupus Education|16-41-18.5-1. State Department Working With National Lupus Organization in Educating the Public

Sec. 1. The state department may work with a national lupus organization in educating the public about the following concerning lupus:(1) The symptoms and nature of lupus.(2) Personal risk factors.(3) Options for diagnosing and treating lupus.(4) Populations with elevated risk for lupus, including women and communities of color.As added by P.L.108-2011, SEC.1.
IN Code § 16-41-18.5-2 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18.5. Lupus Education|16-41-18.5-2. State Department Promoting National Organization's Lupus Education Initiatives; Distribution of Health Information on State Department Web Site

Sec. 2. (a) The state department may promote a national lupus organization's initiatives to educate and train physicians, other health care providers, and human services providers on the most current and accurate scientific and medical information regarding the following concerning lupus:(1) Diagnosis.(2) Treatment.(3) Risks and benefits of medications.(4) Research advances.(5) Therapeutic decision making, including medical best practices for diagnosing and treatment.(b) The state department may distribute medically sound health information on the state department's Internet web site for review by the following:(1) Local health departments.(2) Schools.(3) The division of aging.(4) Employer wellness programs.(5) Physicians and other health care providers.(6) Hospitals.As added by P.L.108-2011, SEC.1.
IN Code § 16-41-18.5-3 (2021)
2021 Indiana Code|Title 16. Health|Article 41. Public Health Measures for the Prevention and Control of Disease|Chapter 18.5. Lupus Education|16-41-18.5-3. Participation in Identifying Partners for Lupus Education

Sec. 3. The state department may participate in identifying the appropriate partners to aid in the education components of this chapter, including the following:(1) Local health departments.(2) Schools.(3) Division of aging.(4) Area agencies on aging.(5) Employer wellness programs.(6) Physicians and other health care providers.(7) Accident and sickness insurance companies and health maintenance organizations.(8) Hospitals.(9) Women's health organizations.(10) Nonprofit entities.(11) Community organizations.As added by P.L.108-2011, SEC.1.